ABT-491 hydrochloride, >=98% (HPLC)

ABT-491 hydrochloride, >=98% (HPLC)

Biochem/physiol Actions

Highly potent, selective and orally active platelet-activating factor (PAF) receptor antagonist. Ki = 0.6 nM in human platelets.

Features and Benefits

This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the PAF Receptor page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level mp InChI key InChI Manufacturer Form Assay Price Quantity
3573265 ABT-491 hydrochloride, >=98% (HPLC) white to beige 100 170-178 °C (lit.) AWRGBOKANQBIBM-UHFFFAOYSA-N 1S/C28H22FN5O2.ClH/c1-5-18-7-6-8-25-26(18)21(16-34(25)28(36)32(3)4)27(35)19-9-10-20(22(29)13-19)15-33-17(2)31-23-14-30-12-11-24(23)33;/h1,6-14,16H,15H2,2-4H3;1 SIGMA-ALDRICH solid ≥98% (HPLC)
£1,108.71 (exc VAT) per 25MG
-
+
3573266 ABT-491 hydrochloride, >=98% (HPLC) white to beige 100 170-178 °C (lit.) AWRGBOKANQBIBM-UHFFFAOYSA-N 1S/C28H22FN5O2.ClH/c1-5-18-7-6-8-25-26(18)21(16-34(25)28(36)32(3)4)27(35)19-9-10-20(22(29)13-19)15-33-17(2)31-23-14-30-12-11-24(23)33;/h1,6-14,16H,15H2,2-4H3;1 SIGMA-ALDRICH solid ≥98% (HPLC)
£366.32 (exc VAT) per 5MG
-
+